Cloning, characterization, and heterologous expression of a candidate hirudin gene from the salivary gland transcriptome of Hirudo nipponia
Recombinant expression study published in Scientific Reports (2023)
Abstract
Hirudin is a pharmacologically active substance in leeches with potent blood anticoagulation properties. Although recombinant hirudin production isolated from Hirudo medicinalis Linnaeus and Hirudinaria manillensis Lesson is known, to our knowledge, this study is the first to report recombinant hirudin expression and production from Hirudo nipponia Whitman. Thus, the present study aimed to clone and characterize the full-length cDNA of a candidate hirudin gene (c16237_g1), which is localized on the salivary gland transcriptome of H. nipponia, and further evaluate its recombinant production using a eukaryotic expression system. The 489-bp cDNA possessed several properties of the hirudin "core" motifs associated with binding to the thrombin catalytic pocket. A fusion expression vector (pPIC9K-hirudin) was constructed and successfully transformed into Pichia pastoris strain GS115 via electroporation. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis and western blot analysis confirmed hirudin expression. The recombinant protein was expressed with a yield of 6.68 mg/L culture. Mass spectrometry analysis further confirmed target protein expression. The concentration and antithrombin activity of purified hirudin were 1.67 mg/mL and 14,000 ATU/mL, respectively. These findings provide a basis for further elucidating the molecular anticoagulation mechanism of hirudin, and address China's growing market demand for engineered H. nipponia-derived hirudin and hirudin-based drugs.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Summary
First report of recombinant hirudin from Hirudo nipponia: a candidate cDNA from the salivary gland transcriptome was expressed in Pichia pastoris at 6.68 mg/L, and purified hirudin (1.67 mg/mL) showed antithrombin activity of 14,000 ATU/mL.
Why This Matters for Hirudotherapy
Researchers cloned and characterized a candidate hirudin gene from the salivary gland transcriptome of the medicinal leech Hirudo nipponia, achieving successful heterologous expression of the recombinant protein. The purified recombinant hirudin demonstrated potent antithrombin activity, establishing a viable biotechnological method to produce this key anticoagulant. The main caveat is that the findings represent strictly preclinical, in-vitro biomanufacturing data; the abstract provides no clinical trials or in-vivo efficacy data for this specific H. nipponia derivative.
Citation
Reference (Vancouver style)
Shi P, Wei J, You H, Chen S, Tan F, Lu Z. Cloning, characterization, and heterologous expression of a candidate hirudin gene from the salivary gland transcriptome of Hirudo nipponia. Sci Rep. 2023;13(1):4943. doi:10.1038/s41598-023-32303-2. PMID: 36973525
Bibliographic details (authors, volume, pages, DOI) are taken from the PubMed record.
Added to ASH library: May 27, 2026 · Site last updated: June 18, 2026